The Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that has been shown to act as ...

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across the globe, including in areas where the PURPOSE trials were conducted.

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The Food and Drug Administration approved the first injectable HIV prevention medication, which could be a massive step forward in ending the long-term epidemic.

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...

Funds will be used to create a support network for providers of HIV/AIDS care Holy Cross Health has received a three-year grant from ViiV Positive Action Network to develop a support network for peers ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Name three LGBTQ historical figures (a) with a connection to Washington, D.C., and (b) who were or are Jewish.

What is the history of the AIDS epidemic, when did treatment become widely available, and what are the current goals for ending this epidemic?

Malaria is one of the deadliest diseases spread by mosquitoes. Each year, hundreds of millions of people worldwide are ...